Hyperparathyroidism: Clinical Trials

414 trials for Hyperparathyroidism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

266 completed, 51 unknown, 41 recruiting, 25 terminated. 79 Not applicable, 64 Phase 4, 63 Phase 3, 60 Phase 2, 24 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable79Completed 51, Unknown 9, Recruiting 8, Withdrawn 5, Terminated 3, Active not recruiting 2, Not yet recruiting 1
Phase 464Completed 47, Terminated 6, Unknown 5, Recruiting 3, Withdrawn 2, Active not recruiting 1
Phase 363Completed 48, Terminated 5, Recruiting 4, Unknown 4, Not yet recruiting 1, Withdrawn 1
Phase 260Completed 42, Unknown 5, Recruiting 4, Terminated 4, Withdrawn 3, Active not recruiting 1, Not yet recruiting 1
Phase 124Completed 21, Terminated 1, Unknown 1, Withdrawn 1
Early Phase 13Completed 2, Unknown 1

Follow Hyperparathyroidism: new trials by email Literature Review of Hyperparathyroidism trials Research Report on Hyperparathyroidism

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes
RecruitingBettina Mittendorfer1002027-01-012026-05-07
A Study of PLS240 in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
PLS240, Standard of Care - Chronic Kidney Disease (CKD), Secondary Hyperparathyroidism
Phase 3Not yet recruitingPathalys Pharma562026-10-302026-10-22
Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism
Scheduling Navigation, Without Scheduling Navigation - Hyperparathyroidism, Primary
Not applicableRecruitingUniversity of Pennsylvania762026-10-012026-08-27
Osteoporosis & Renal Disease: Research in Primary Health Care Services
Fracture risk assessment tool (FRAX), Dual-Energy X-ray Absorptiometry (DXA) - Osteoporosis, Chronic Kidney Disease Mineral and Bone Disorder
Not yet recruitingUniversidade do Porto6222026-10-012026-09-30
Hyperparathyroidism and Dialysis Adequacy in Hemodialysis Patients
Hyperparathyroidism, Secondary, Kidney Failure, Chronic
Not yet recruitingAssiut University1302026-09-102026-09-15
NIRAF-camera Versus Conventional Surgery in Preoperative Imaging Negative Primary Hyperparathyroidism
NIRAF-camera - Primary Hyperparathyroidism
Not applicableRecruitingThe Cleveland Clinic802026-08-312026-09-11
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
CTAP101 - CKD Stage 3, CKD Stage 4
Phase 2RecruitingOPKO Health, Inc.402026-08-052026-08-20
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
Low-dose Colchicine at 0.5mg daily, Usual Care - Chronic Kidney Disease Mineral and Bone Disorder, Hypertension
Phase 2Not yet recruitingUniversity of Texas Southwestern Medical Center602026-07-012026-06-22
Medium Cut-Off and High-Flux Membranes on Mineral and Bone Metabolism in Hemodialysis Patients
Medium Cut-Off Hemodialysis Membrane, High-Flux Hemodialysis Membrane - End Stage Kidney Disease (ESKD), Hemodialysis
Not applicableActive not recruitingGazi University302026-07-012026-09-14
Shortwave Infrared Surgical Imaging Device Study
Observational study of SWIR imaging device in surgery - Cholecystitis, Cholecystitis, Chronic
Enrolling by invitationCision Vision, Inc.502026-05-292026-08-04
Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet
Supplementary blood samples and urines samples - Children Over 3 Undergoing Dialysis With Secondary Hyperparathyroidism
RecruitingHospices Civils de Lyon202026-04-292026-05-22
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
18F-FCH, NeuroEXPLORER - Primary Hyperparathyroidism, Parathyroid Cancer
Phase 2 / Phase 3RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1932026-04-162026-06-02
Parathyroidectomy After Kidney Transplantation
Subtotal Parathyroidectomy, Conservative Management - Hyperparathyroidism, Kidney Transplantation Recipients
Not applicableRecruitingAarhus University Hospital852026-03-032026-06-26
Aldosterone Variations in Patients With Primary Hyperparathyroidism After Surgery
Primary Hyperparathyroidism, Primary Hyperparathyroidism Due to Adenoma
Not yet recruitingCentral Hospital, Nancy, France4002026-02-012026-02-05
The CPH-MBD Cohort
Chronic Kidney Disease Mineral and Bone Disorder, Chronic Kidney Disease (CKD)
RecruitingHerlev Hospital10002026-01-072026-09-16
Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders
Osteoporosis, Hypercalcemia
RecruitingMartin Blomberg Jensen200002026-01-012026-09-17
The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations
CKD, Renal Insufficiency Chronic
RecruitingUniversity of Copenhagen502025-12-152025-12-31
The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density
Treat to target - Chronic Kidney Disease Mineral and Bone Disorder
Not applicableRecruitingHerlev Hospital702025-11-202026-01-06
Parathyroid Adenoma Detection With Rubidium-82 Imaging
PET/CT imaging with rubidium-82 - Parathyroid Adenomas, Hyperparathyroidism, Primary
Not yet recruitingMatthieu Pelletier-Galarneau, MD MSc202025-11-012025-08-22
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
MT1013, Cinacalcet - Secondary Hyperparathyroidism, Chronic Kidney Disease
Phase 3RecruitingShaanxi Micot Pharmaceutical Technology Co., Ltd.4242025-09-302025-10-01

Showing 20 of 414. Sign in to see all of them.

Narrower conditions

Hyperparathyroidism, Secondary (184)  ·  Hyperparathyroidism, Primary (101)  ·  Renal Insufficiency, Chronic (101)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (73)  ·  Kidney Failure, Chronic (50)  ·  Parathyroid Neoplasms (28)  ·  Vitamin D Deficiency (28)  ·  Hypercalcemia (26)  ·  Osteoporosis (24)  ·  Parathyroid Diseases (16)  ·  Bone Diseases, Metabolic (15)  ·  Renal Insufficiency (15)  ·  Kidney Diseases (14)  ·  Hypocalcemia (12)

Broader conditions

Endocrine System Diseases (409)  ·  Parathyroid Diseases (398)  ·  Pathological Conditions, Signs and Symptoms (185)  ·  Pathologic Processes (179)  ·  Male Urogenital Diseases (178)  ·  Urogenital Diseases (178)  ·  Female Urogenital Diseases (177)  ·  Female Urogenital Diseases and Pregnancy Complications (177)  ·  Urologic Diseases (177)  ·  Disease Attributes (174)  ·  Chronic Disease (170)  ·  Kidney Diseases (163)  ·  Nutritional and Metabolic Diseases (161)  ·  Metabolic Diseases (147)

Interventions

Cinacalcet (59)  ·  paricalcitol (35)  ·  Calcitriol (19)  ·  etelcalcetide hydrochloride (18)  ·  1 alpha-hydroxyergocalciferol (14)  ·  Cholecalciferol (14)  ·  Parathyroidectomy (13)  ·  Vitamin D (12)  ·  Standard of Care (9)  ·  Denosumab (6)  ·  Ergocalciferols (6)  ·  Sevelamer (6)  ·  Calcifediol (5)  ·  alfacalcidol (5)  ·  Blood Specimen Collection (4)

Sponsors

Amgen (43)  ·  Abbott (13)  ·  AbbVie (prior sponsor, Abbott) (12)  ·  Kyowa Kirin Co., Ltd. (10)  ·  Columbia University (8)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (8)  ·  OPKO Health, Inc. (7)  ·  M.D. Anderson Cancer Center (6)  ·  KAI Pharmaceuticals (5)  ·  OPKO IP Holdings II, Inc. (5)  ·  Shanghai Hengrui Pharmaceutical Co., Ltd. (5)  ·  Genzyme, a Sanofi Company (4)  ·  Medical University of Vienna (4)  ·  Shaanxi Micot Pharmaceutical Technology Co., Ltd. (4)  ·  The Cleveland Clinic (4)

Countries

United States (134)  ·  China (35)  ·  France (31)  ·  Italy (30)  ·  Denmark (23)  ·  Japan (21)  ·  Germany (20)  ·  Poland (20)  ·  Spain (17)  ·  Russia (16)  ·  Belgium (14)  ·  Canada (14)  ·  Austria (13)  ·  Czechia (13)  ·  Hungary (12)

Top investigators

Joel Melnick, MD (7)  ·  Nancy D. Perrier, MD (5)  ·  Smita Jha, M.D. (4)  ·  M D (3)  ·  Thomas Nickolas, MD, MS (3)  ·  Ann Eldred, MD (2)  ·  Bruno Niederle, Prof., MD (2)  ·  Christos Argyropoulos, MD (2)  ·  Ditte Hansen, MD, PhD (2)  ·  Ditte Hansen, Medical doctor, professor (2)  ·  Dongliang Zhang, Doctor (2)  ·  Efstathios Mitsopoulos, MD (2)  ·  Gregory Bell, MD (2)

Results publications

PMID 40576086, PMID 40668552, PMID 20943783, PMID 21544866, PMID 27532368, PMID 10654517, PMID 10898180, PMID 11114637, PMID 11114639, PMID 11229970, PMID 11576947, PMID 14668730, PMID 15284307, PMID 15522938, PMID 15663056, PMID 15689407, PMID 15698460, PMID 15711996, PMID 15726399, PMID 15828905, PMID 15930998, PMID 15983958, PMID 16105056, PMID 16540904, PMID 16785355, PMID 16792136, PMID 17071309, PMID 17216827, PMID 17244780, PMID 17284629, PMID 17556697, PMID 17591525, PMID 17666472, PMID 17699221, PMID 17879694, PMID 18178780, PMID 18310602, PMID 18385391, PMID 18397701, PMID 18423809, PMID 18793528, PMID 19018785, PMID 19160424, PMID 19351725, PMID 19365139, PMID 19470620, PMID 19480654, PMID 19776051, PMID 19778452, PMID 19836494

NIH funding

2008 (3), 2023 (3), R01CA212147 (3), 2009 (2), 2018 (2), R01DK032333 (2), R01DK073039 (2), R01DK084986 (2), 2014 (1), 2015 (1), 2016 (1), 2017 (1), K23DK136930 (1), M01RR000042 (1), P30AG028740 (1)